Abstract
ObjectiveTo analyze the results of the XEN45 implant in our hospital center, both in terms of efficacy and safety. MethodsObservational, retrospective, single-center study of patients undergoing XEN45 surgery at the University Hospital of Jaén between January 1, 2018 and June 31, 2021. ResultsA total of 73 patients were implanted with the XEN45 device (48 with in combined surgery with phacoemulsification of the crystalline lens and 25 standalone XEN45 surgery). IOP decreased from 19.9±4.9mmHg at the first visit to a mean of 17.1±5.3 (P=.001) at the sixth month. Drug use required between the first visit and XEN implantation was reduced from 2.1±0.9 to 0.6 (P<.000). A second surgery was necessary in 18 patients (26.6%) in the first 6 months. ConclusionsGlaucoma surgery by XEN45 implant, alone or combined with cataract surgery, is an effective and safe procedure for IOP lowering.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
